Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top ...
GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...
Patients with low-gradient aortic stenosis and reduced LVEF, compared with patients with high-gradient aortic stenosis, have worse clinical outcomes.
Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback